These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 8866584)

  • 21. Effect of salbutamol and ipratropium bromide on airway calibre and bronchial reactivity in asthma and chronic bronchitis.
    Higgins BG; Powell RM; Cooper S; Tattersfield AE
    Eur Respir J; 1991 Apr; 4(4):415-20. PubMed ID: 1830277
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tolerance to the protective effects of salmeterol on methacholine-induced bronchoconstriction: influence of inhaled corticosteroids.
    Boulet LP; Cartier A; Milot J; Côté J; Malo JL; Laviolette M
    Eur Respir J; 1998 May; 11(5):1091-7. PubMed ID: 9648961
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Study of ipratropium bromide inhalation in stable asthma.
    Ailani RK; Shah SP; Koyande D; Kudalkar SS; Kodge K; Deshmukh YA
    J Assoc Physicians India; 1995 Jan; 43(1):36, 41. PubMed ID: 9282638
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of ipratropium bromide in acute childhood asthma: a meta-analysis.
    Osmond MH; Klassen TP
    Acad Emerg Med; 1995 Jul; 2(7):651-6. PubMed ID: 8521214
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effects of the combination of inhaled ipratropium and oral theophylline in asthma.
    Burki NK
    Chest; 1997 Jun; 111(6):1509-13. PubMed ID: 9187165
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bronchodilating effect of combined therapy with ipratropium bromide and ondansetron in patients with COPD.
    Pauwels R; Joos GF; Fogarty C; Faiferman I; Hirschberg S; Vessey R; Wouters EF
    Pulm Pharmacol Ther; 2008; 21(2):385-92. PubMed ID: 18023600
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Airway reactivity is a determinant of bronchodilator responsiveness after methacholine-induced bronchoconstriction.
    Parker AL
    J Asthma; 2004 Sep; 41(6):671-7. PubMed ID: 15584317
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and safety of ipratropium bromide/albuterol compared with albuterol in patients with moderate-to-severe asthma: a randomized controlled trial.
    Donohue JF; Wise R; Busse WW; Garfinkel S; Zubek VB; Ghafouri M; Manuel RC; Schlenker-Herceg R; Bleecker ER
    BMC Pulm Med; 2016 Apr; 16(1):65. PubMed ID: 27130202
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Addition of anticholinergic solution prolongs bronchodilator effect of beta 2 agonists in patients with chronic obstructive pulmonary disease.
    Levin DC; Little KS; Laughlin KR; Galbraith JM; Gustman PM; Murphy D; Kram JA; Hardie G; Reuter C; Ostransky D; McFarland K; Petty TL; Silvers W; Rennard SI; Mueller M; Repsher LH; Zuwallack RL; Vale R
    Am J Med; 1996 Jan; 100(1A):40S-48S. PubMed ID: 8610716
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tolerance to beta-agonists during acute bronchoconstriction.
    Hancox RJ; Aldridge RE; Cowan JO; Flannery EM; Herbison GP; McLachlan CR; Town GI; Taylor DR
    Eur Respir J; 1999 Aug; 14(2):283-7. PubMed ID: 10515402
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of cessation of terbutaline treatment on airway obstruction and responsiveness in patients with chronic obstructive pulmonary disease.
    de Jong JW; Koëter GH; van der Mark TW; Postma DS
    Thorax; 1996 Jul; 51(7):684-8. PubMed ID: 8882073
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bronchodilator effect of Ipraterol on methacholine-induced bronchoconstriction in asthmatic patients.
    Maneechotesuwan K; Suthamsmai T; Ratanasaenglert K; Pipopsuthipaiboon S
    J Med Assoc Thai; 2011 Feb; 94 Suppl 1():S66-71. PubMed ID: 21728272
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhaled salmeterol: a review of its efficacy in chronic obstructive pulmonary disease.
    Jarvis B; Markham A
    Drugs Aging; 2001; 18(6):441-72. PubMed ID: 11419918
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Periodic treatment regimens with inhaled steroids in asthma or chronic obstructive pulmonary disease. Is it possible?
    van Schayck CP; van den Broek PJ; den Otter JJ; van Herwaarden CL; Molema J; van Weel C
    JAMA; 1995 Jul; 274(2):161-4. PubMed ID: 7596005
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A multicenter study of nebulized bronchodilator solutions in chronic obstructive pulmonary disease.
    Friedman M
    Am J Med; 1996 Jan; 100(1A):30S-39S. PubMed ID: 8610715
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effect of ipratropium bromide on histamine-induced bronchoconstriction in subjects with chronic airway obstruction].
    Nannini LJ
    Medicina (B Aires); 2001; 61(3):262-6. PubMed ID: 11474870
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dose response study of ipratropium bromide aerosol on maximum exercise performance in stable patients with chronic obstructive pulmonary disease.
    Ikeda A; Nishimura K; Koyama H; Tsukino M; Mishima M; Izumi T
    Thorax; 1996 Jan; 51(1):48-53. PubMed ID: 8658369
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A meta-analysis of the effects of ipratropium bromide in adults with acute asthma.
    Rodrigo G; Rodrigo C; Burschtin O
    Am J Med; 1999 Oct; 107(4):363-70. PubMed ID: 10527039
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Daily variation in lung function in COPD patients with combined albuterol and ipratropium: results from a 4-week, randomized, crossover study.
    Singh D; Zhu CQ; Sharma S; Church A; Kalberg CJ
    Pulm Pharmacol Ther; 2015 Apr; 31():85-91. PubMed ID: 25197005
    [TBL] [Abstract][Full Text] [Related]  

  • 40. First-line therapy for adult patients with acute asthma receiving a multiple-dose protocol of ipratropium bromide plus albuterol in the emergency department.
    Rodrigo GJ; Rodrigo C
    Am J Respir Crit Care Med; 2000 Jun; 161(6):1862-8. PubMed ID: 10852758
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.